story of the week
Mavacamten for Treatment of Symptomatic Obstructive Hypertrophic Cardiomyopathy
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The Lancet
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Mavacamten for Treatment of Symptomatic Obstructive Hypertrophic Cardiomyopathy (EXPLORER-HCM): A Randomised, Double-Blind, Placebo-Controlled, Phase 3 Trial
Lancet 2020 Aug 28;[EPub Ahead of Print], I Olivotto, A Oreziak, R Barriales-Villa, TP Abraham, A Masri, P Garcia-Pavia, S Saberi, NK Lakdawala, MT Wheeler, A Owens, M Kubanek, W Wojakowski, MK Jensen, J Gimeno-Blanes, K Afshar, J Myers, SM Hegde, SD Solomon, AJ Sehnert, D Zhang, W Li, M Bhattacharya, JM Edelberg, CB Waldman, SJ Lester, A Wang, CY Ho, D JacobyFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.